{"id":"W2892288216","doi":"10.1016/j.jaci.2018.08.022","title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","year":2018,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":678,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Janssen Biotech; Allergan; LEO Pharma; Eli Lilly and Company; Galderma; Dermira; Celgene; Regeneron Pharmaceuticals; Novartis; Maruho; Amgen; Pfizer; AbbVie; Sanofi; Merck","keywords":"Dupilumab; Atopic dermatitis; SCORAD; Filaggrin; Eczema Area and Severity Index; Medicine; Placebo; Loricrin; Internal medicine; Immunology; Pathology; Psoriasis; Dermatology Life Quality Index; Biology; Keratinocyte; Involucrin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001193276,0.0004773712,0.001244042,0.0002621356,0.0001617258,0.0003830887,0.0001899169,0.0002115944,0.001198711],"category_scores_gemma":[0.000757132,0.0001538008,0.00103808,0.0003190204,0.0001377305,0.0001935663,0.0001352722,0.0004701228,0.0001237384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003135175,"about_ca_system_score_gemma":0.0001795102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00054731,"about_ca_topic_score_gemma":0.001608172,"domain_scores_codex":[0.9996359,0.000171973,0.00003234447,0.00008219486,0.000046946,0.00003059181],"domain_scores_gemma":[0.9995393,0.0002164884,0.0001176704,0.00002799017,0.00006003904,0.00003855956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.165145,0.001734986,0.1818099,0.01307592,0.02343859,0.0005693106,0.0002221915,0.001999552,0.07326017,0.0002816019,0.008231567,0.5302312],"study_design_scores_gemma":[0.03799788,0.0596444,0.8116809,0.001252274,0.04191976,0.003404966,0.0003615903,0.004229708,0.01686727,0.0008438908,0.02171981,0.00007761082],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8949161,0.1003718,0.0005510894,0.0004157265,0.0001446785,0.0001619288,0.001021248,0.00009204715,0.002325323],"genre_scores_gemma":[0.9889516,0.008921928,0.0005220996,0.0005720314,0.0001051581,0.00005205323,0.0005043116,0.000007569674,0.0003632825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001244042,"threshold_uncertainty_score":0.006310701,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008808492719377024,"score_gpt":0.2738651296625087,"score_spread":0.2650566369431317,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}